Product
Blood for cfDNA
1 clinical trial
2 indications
Indication
Stomach AdenocarcinomaIndication
Gastroesophageal Junction AdenocarcinomaClinical trial
Ramucirumab Plus Irinotecan in Patients With Previously Treated Advanced Gastric or Gastro-esophageal Junction AdenocarcinomaStatus: Completed, Estimated PCD: 2023-04-14